ACHIEVE LIFE SCIENCES, INC.

ACHV is the ticker symbol for ACHIEVE LIFE SCIENCES, INC., a publicly traded US company.

Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.

Key metrics include a return on equity of -95.2%, a debt-to-equity ratio of 2.10.

The company reports trailing twelve-month revenue of $0 and net loss of $10.17M.

FINOTAUR aggregates real-time and fundamental data on ACHV to help traders and investors make informed decisions. Track ACHV in your trading journal alongside other positions for a unified view of your portfolio.